End to End Versus Side to End Anastomosis After Anterior Resection of Cancer Rectum

NCT ID: NCT06311279

Last Updated: 2024-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-05

Study Completion Date

2025-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison between end to end and side to end anastomosis after anterior resection of cancer rectum and compare the outcomes of both surgical techniques. The main outcomes were bowel functional outcomes and QoL. Bowel functional outcomes mainly included three indexes: stool frequency, urgency, incomplete defecation, and incontinence. The secondary outcomes were surgical outcomes including operative time, postoperative hospital stay, postoperative complications, reoperation, and mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During the past two decades, remarkable progress has been made in the treatment of rectal cancer. The main goal of rectal surgery for malignancy is oncologic radicality in an effort to achieve the preservation of sphincters and sexual-urinary function.The introduction of circular stapling devices is largely responsible for their increasing popularity and utilization. Sphincter-saving procedures associated to partial or total mesorectal excision (TME) for the treatment of mid and distal rectal cancer have become increasingly prevalent as their safety and efficacy have been proved. Total mesorectal excision (TME) is the best available treatment for rectal cancer. With the advancement of surgical techniques, the majority of patients with mid and upper rectal cancer can undergo a sphincter-saving TME procedure. After TME, the most widely used reconstructive technique is straight coloanal anastomosis. With the advancement of surgical technique, the local recurrence rate after rectal cancer surgery has been decreased from 25-50% to 3-8%. Naturally, it is time to focus on how to improve bowel functional outcomes and quality of life (QoL) for rectal cancer patients. However, because the sigmoid colon is usually excised during surgery which decreases the storage volume of stool, there is a common problem seriously influencing the life quality of patients, including increased tool frequency, urgency and incontinence, which is termed as anterior resection syndrome (ARS). About 19-56% of patients would suffer from ARS. Thus, the demand for a technique with better functional outcomes made surgeons modify the straight anastomotic technique. Thus, another modified anastomotic technique, side-to-end anastomosis, which has been used since 1966, has gained attention. Side-to-end anastomosis usually needs a 3-5 cm-long colonic segment. Multiple studies on the literature have shown that compared with straight anastomosis, side-to-end anastomosis has advantages in bowel functional and operative outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectum Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Comparison between end to end and side to end anastomosis after anterior resection of cancer rectum and compare the outcomes of both surgical techniques. The main outcomes were bowel functional outcomes and QoL. Bowel functional outcomes mainly included three indexes: stool frequency, urgency, incomplete defecation, and incontinence. The secondary outcomes were surgical outcomes including operative time, postoperative hospital stay, postoperative complications, reoperation, and mortality
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
randomized comparative clinical trial

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

the first group included patients who will have anterior resection with end-to-end anastomosis

Group Type ACTIVE_COMPARATOR

Anterior resection of Rectal cancer

Intervention Type PROCEDURE

Anterior resection of cancer rectum and type of anastomosis (End to end or side to end)

Group B

the second group included patients will have anterior resection with side to end anastomosis.

Group Type ACTIVE_COMPARATOR

Anterior resection of Rectal cancer

Intervention Type PROCEDURE

Anterior resection of cancer rectum and type of anastomosis (End to end or side to end)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anterior resection of Rectal cancer

Anterior resection of cancer rectum and type of anastomosis (End to end or side to end)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age to 80 years.
* Laparoscopic or open anterior resection of cancer rectum.

Exclusion Criteria

* synchronous colorectal carcinoma
* emergency surgery
* history of colon or rectal segmental resections
* fixed rectal carcinoma who received preoperative radiotherapy
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nabil Abdelnaser Al-ameer

assistant lecturer, physician and MD candidate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

AbdElhafez H Mohamed, MD

Role: STUDY_CHAIR

Sohag University

Ahmed A Ahmed, MD

Role: STUDY_DIRECTOR

Ain Shams University

Nabil A Al-Ameer, MD

Role: PRINCIPAL_INVESTIGATOR

Sohag University

Emad G Mohamed, MD

Role: STUDY_DIRECTOR

Sohag University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag university

Sohag, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nabil A Al-Ameer, MD

Role: CONTACT

1118416290 ext. 0020

Nabil A Al-Ameer, MD

Role: CONTACT

1067833019 ext. 0020

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nabil A Al-Ameer, MD

Role: primary

1118416290

Ahmed G Hassanein, MD

Role: backup

1552538300 ext. 0020

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-24-03-01MD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.